nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—lung cancer	0.191	0.48	CbGaD
Selegiline—CYP2E1—lung cancer	0.136	0.341	CbGaD
Selegiline—ABCB1—lung cancer	0.0712	0.179	CbGaD
Selegiline—CYP2C19—Gefitinib—lung cancer	0.0162	0.0445	CbGbCtD
Selegiline—CYP2C19—Teniposide—lung cancer	0.0157	0.0431	CbGbCtD
Selegiline—ABCB1—Topotecan—lung cancer	0.0143	0.0392	CbGbCtD
Selegiline—CYP2B6—Irinotecan—lung cancer	0.0136	0.0374	CbGbCtD
Selegiline—CYP2C9—Gefitinib—lung cancer	0.0135	0.037	CbGbCtD
Selegiline—ABCB1—Gefitinib—lung cancer	0.0131	0.0359	CbGbCtD
Selegiline—CYP2C9—Teniposide—lung cancer	0.0131	0.0359	CbGbCtD
Selegiline—CYP2D6—Gefitinib—lung cancer	0.0123	0.0338	CbGbCtD
Selegiline—CYP2C8—Erlotinib—lung cancer	0.0114	0.0313	CbGbCtD
Selegiline—CYP2B6—Cisplatin—lung cancer	0.0111	0.0305	CbGbCtD
Selegiline—CYP2E1—Etoposide—lung cancer	0.011	0.0303	CbGbCtD
Selegiline—CYP2C8—Paclitaxel—lung cancer	0.0104	0.0287	CbGbCtD
Selegiline—ABCB1—Vinorelbine—lung cancer	0.0101	0.0276	CbGbCtD
Selegiline—CYP2D6—Vinorelbine—lung cancer	0.00948	0.026	CbGbCtD
Selegiline—CYP1A2—Erlotinib—lung cancer	0.00883	0.0243	CbGbCtD
Selegiline—CYP3A4—Topotecan—lung cancer	0.00856	0.0235	CbGbCtD
Selegiline—CYP2C8—Etoposide—lung cancer	0.00825	0.0227	CbGbCtD
Selegiline—ABCB1—Crizotinib—lung cancer	0.00801	0.022	CbGbCtD
Selegiline—CYP3A4—Gefitinib—lung cancer	0.00783	0.0215	CbGbCtD
Selegiline—ABCB1—Gemcitabine—lung cancer	0.00783	0.0215	CbGbCtD
Selegiline—ABCB1—Erlotinib—lung cancer	0.00772	0.0212	CbGbCtD
Selegiline—CYP3A4—Teniposide—lung cancer	0.00759	0.0209	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—lung cancer	0.00743	0.0204	CbGbCtD
Selegiline—CYP2C9—Paclitaxel—lung cancer	0.00729	0.02	CbGbCtD
Selegiline—CYP2D6—Erlotinib—lung cancer	0.00728	0.02	CbGbCtD
Selegiline—ABCB1—Paclitaxel—lung cancer	0.00707	0.0194	CbGbCtD
Selegiline—ABCB1—Irinotecan—lung cancer	0.00698	0.0192	CbGbCtD
Selegiline—CYP1A2—Etoposide—lung cancer	0.00639	0.0176	CbGbCtD
Selegiline—ABCB1—Vinblastine—lung cancer	0.0062	0.017	CbGbCtD
Selegiline—CYP3A4—Vinorelbine—lung cancer	0.00603	0.0166	CbGbCtD
Selegiline—CYP2C9—Cisplatin—lung cancer	0.00586	0.0161	CbGbCtD
Selegiline—CYP2D6—Vinblastine—lung cancer	0.00584	0.0161	CbGbCtD
Selegiline—ABCB1—Cisplatin—lung cancer	0.00569	0.0156	CbGbCtD
Selegiline—ABCB1—Etoposide—lung cancer	0.00559	0.0153	CbGbCtD
Selegiline—ABCB1—Docetaxel—lung cancer	0.00511	0.014	CbGbCtD
Selegiline—CYP3A4—Crizotinib—lung cancer	0.0048	0.0132	CbGbCtD
Selegiline—CYP3A4—Erlotinib—lung cancer	0.00463	0.0127	CbGbCtD
Selegiline—CYP3A4—Paclitaxel—lung cancer	0.00424	0.0116	CbGbCtD
Selegiline—CYP3A4—Irinotecan—lung cancer	0.00418	0.0115	CbGbCtD
Selegiline—ABCB1—Doxorubicin—lung cancer	0.00381	0.0105	CbGbCtD
Selegiline—CYP3A4—Vinblastine—lung cancer	0.00372	0.0102	CbGbCtD
Selegiline—ABCB1—Methotrexate—lung cancer	0.00369	0.0101	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—lung cancer	0.00359	0.00986	CbGbCtD
Selegiline—CYP3A4—Etoposide—lung cancer	0.00335	0.0092	CbGbCtD
Selegiline—CYP3A4—Docetaxel—lung cancer	0.00306	0.00841	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—lung cancer	0.00228	0.00627	CbGbCtD
Selegiline—Pseudoephedrine—IL2—lung cancer	0.000624	0.489	CrCbGaD
Selegiline—Amphetamine—CYP2A6—lung cancer	0.000186	0.145	CrCbGaD
Selegiline—Benzyl alcohol—CYP2E1—lung cancer	0.000165	0.129	CrCbGaD
Selegiline—Benzyl alcohol—CYP1A1—lung cancer	0.000163	0.128	CrCbGaD
Selegiline—Phenelzine—CYP2E1—lung cancer	0.00014	0.109	CrCbGaD
Selegiline—Decreased appetite—Paclitaxel—lung cancer	3.79e-05	0.000247	CcSEcCtD
Selegiline—Dry mouth—Docetaxel—lung cancer	3.77e-05	0.000245	CcSEcCtD
Selegiline—Gastrointestinal disorder—Paclitaxel—lung cancer	3.76e-05	0.000245	CcSEcCtD
Selegiline—Fatigue—Paclitaxel—lung cancer	3.75e-05	0.000245	CcSEcCtD
Selegiline—Hepatitis—Methotrexate—lung cancer	3.74e-05	0.000244	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—lung cancer	3.74e-05	0.000244	CcSEcCtD
Selegiline—Asthenia—Gemcitabine—lung cancer	3.73e-05	0.000243	CcSEcCtD
Selegiline—Constipation—Paclitaxel—lung cancer	3.72e-05	0.000243	CcSEcCtD
Selegiline—Pain—Paclitaxel—lung cancer	3.72e-05	0.000243	CcSEcCtD
Selegiline—Confusional state—Docetaxel—lung cancer	3.72e-05	0.000242	CcSEcCtD
Selegiline—Pharyngitis—Methotrexate—lung cancer	3.72e-05	0.000242	CcSEcCtD
Selegiline—Urinary tract disorder—Methotrexate—lung cancer	3.7e-05	0.000241	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—lung cancer	3.7e-05	0.000241	CcSEcCtD
Selegiline—Oedema—Docetaxel—lung cancer	3.69e-05	0.00024	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—lung cancer	3.69e-05	0.00024	CcSEcCtD
Selegiline—Pruritus—Gemcitabine—lung cancer	3.68e-05	0.00024	CcSEcCtD
Selegiline—Urethral disorder—Methotrexate—lung cancer	3.67e-05	0.000239	CcSEcCtD
Selegiline—Infection—Docetaxel—lung cancer	3.67e-05	0.000239	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—lung cancer	3.67e-05	0.000239	CcSEcCtD
Selegiline—Feeling abnormal—Etoposide—lung cancer	3.66e-05	0.000238	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—lung cancer	3.65e-05	0.000238	CcSEcCtD
Selegiline—Diarrhoea—Irinotecan—lung cancer	3.65e-05	0.000238	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—lung cancer	3.63e-05	0.000237	CcSEcCtD
Selegiline—Gastrointestinal pain—Etoposide—lung cancer	3.63e-05	0.000237	CcSEcCtD
Selegiline—Shock—Docetaxel—lung cancer	3.63e-05	0.000237	CcSEcCtD
Selegiline—Nervous system disorder—Docetaxel—lung cancer	3.62e-05	0.000236	CcSEcCtD
Selegiline—Thrombocytopenia—Docetaxel—lung cancer	3.61e-05	0.000235	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—lung cancer	3.61e-05	0.000235	CcSEcCtD
Selegiline—Visual impairment—Methotrexate—lung cancer	3.61e-05	0.000235	CcSEcCtD
Selegiline—Tachycardia—Docetaxel—lung cancer	3.6e-05	0.000235	CcSEcCtD
Selegiline—Feeling abnormal—Paclitaxel—lung cancer	3.59e-05	0.000234	CcSEcCtD
Selegiline—Skin disorder—Docetaxel—lung cancer	3.59e-05	0.000234	CcSEcCtD
Selegiline—Hypersensitivity—Cisplatin—lung cancer	3.57e-05	0.000233	CcSEcCtD
Selegiline—Gastrointestinal pain—Paclitaxel—lung cancer	3.56e-05	0.000232	CcSEcCtD
Selegiline—Diarrhoea—Gemcitabine—lung cancer	3.56e-05	0.000232	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—lung cancer	3.54e-05	0.000231	CcSEcCtD
Selegiline—Dizziness—Irinotecan—lung cancer	3.53e-05	0.00023	CcSEcCtD
Selegiline—Urticaria—Etoposide—lung cancer	3.53e-05	0.00023	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—lung cancer	3.52e-05	0.000229	CcSEcCtD
Selegiline—Anorexia—Docetaxel—lung cancer	3.52e-05	0.000229	CcSEcCtD
Selegiline—Abdominal pain—Etoposide—lung cancer	3.51e-05	0.000229	CcSEcCtD
Selegiline—Body temperature increased—Etoposide—lung cancer	3.51e-05	0.000229	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—lung cancer	3.51e-05	0.000229	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—lung cancer	3.51e-05	0.000229	CcSEcCtD
Selegiline—Tinnitus—Methotrexate—lung cancer	3.49e-05	0.000227	CcSEcCtD
Selegiline—Asthenia—Cisplatin—lung cancer	3.48e-05	0.000227	CcSEcCtD
Selegiline—Sweating—Doxorubicin—lung cancer	3.46e-05	0.000226	CcSEcCtD
Selegiline—Urticaria—Paclitaxel—lung cancer	3.46e-05	0.000225	CcSEcCtD
Selegiline—Hypotension—Docetaxel—lung cancer	3.45e-05	0.000225	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—lung cancer	3.44e-05	0.000224	CcSEcCtD
Selegiline—Abdominal pain—Paclitaxel—lung cancer	3.44e-05	0.000224	CcSEcCtD
Selegiline—Body temperature increased—Paclitaxel—lung cancer	3.44e-05	0.000224	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—lung cancer	3.42e-05	0.000223	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—lung cancer	3.41e-05	0.000222	CcSEcCtD
Selegiline—Angiopathy—Methotrexate—lung cancer	3.4e-05	0.000221	CcSEcCtD
Selegiline—Vomiting—Irinotecan—lung cancer	3.4e-05	0.000221	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—lung cancer	3.39e-05	0.000221	CcSEcCtD
Selegiline—Rash—Irinotecan—lung cancer	3.37e-05	0.000219	CcSEcCtD
Selegiline—Dermatitis—Irinotecan—lung cancer	3.36e-05	0.000219	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Docetaxel—lung cancer	3.36e-05	0.000219	CcSEcCtD
Selegiline—Chills—Methotrexate—lung cancer	3.36e-05	0.000219	CcSEcCtD
Selegiline—Headache—Irinotecan—lung cancer	3.35e-05	0.000218	CcSEcCtD
Selegiline—Insomnia—Docetaxel—lung cancer	3.34e-05	0.000218	CcSEcCtD
Selegiline—Diarrhoea—Cisplatin—lung cancer	3.32e-05	0.000216	CcSEcCtD
Selegiline—Paraesthesia—Docetaxel—lung cancer	3.31e-05	0.000216	CcSEcCtD
Selegiline—Alopecia—Methotrexate—lung cancer	3.31e-05	0.000216	CcSEcCtD
Selegiline—Vomiting—Gemcitabine—lung cancer	3.31e-05	0.000215	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—lung cancer	3.3e-05	0.000215	CcSEcCtD
Selegiline—Dyspnoea—Docetaxel—lung cancer	3.29e-05	0.000214	CcSEcCtD
Selegiline—Somnolence—Docetaxel—lung cancer	3.28e-05	0.000214	CcSEcCtD
Selegiline—Mental disorder—Methotrexate—lung cancer	3.28e-05	0.000214	CcSEcCtD
Selegiline—Rash—Gemcitabine—lung cancer	3.28e-05	0.000214	CcSEcCtD
Selegiline—Dermatitis—Gemcitabine—lung cancer	3.28e-05	0.000213	CcSEcCtD
Selegiline—Hypersensitivity—Etoposide—lung cancer	3.27e-05	0.000213	CcSEcCtD
Selegiline—Malnutrition—Methotrexate—lung cancer	3.26e-05	0.000212	CcSEcCtD
Selegiline—Erythema—Methotrexate—lung cancer	3.26e-05	0.000212	CcSEcCtD
Selegiline—Headache—Gemcitabine—lung cancer	3.26e-05	0.000212	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—lung cancer	3.25e-05	0.000212	CcSEcCtD
Selegiline—Dyspepsia—Docetaxel—lung cancer	3.25e-05	0.000212	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—lung cancer	3.24e-05	0.000211	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—lung cancer	3.23e-05	0.00021	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—lung cancer	3.22e-05	0.00021	CcSEcCtD
Selegiline—Decreased appetite—Docetaxel—lung cancer	3.21e-05	0.000209	CcSEcCtD
Selegiline—Hypersensitivity—Paclitaxel—lung cancer	3.21e-05	0.000209	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—lung cancer	3.2e-05	0.000209	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—lung cancer	3.19e-05	0.000208	CcSEcCtD
Selegiline—Dysgeusia—Methotrexate—lung cancer	3.19e-05	0.000208	CcSEcCtD
Selegiline—Gastrointestinal disorder—Docetaxel—lung cancer	3.19e-05	0.000208	CcSEcCtD
Selegiline—Asthenia—Etoposide—lung cancer	3.19e-05	0.000208	CcSEcCtD
Selegiline—Fatigue—Docetaxel—lung cancer	3.18e-05	0.000207	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—lung cancer	3.18e-05	0.000207	CcSEcCtD
Selegiline—Nausea—Irinotecan—lung cancer	3.17e-05	0.000207	CcSEcCtD
Selegiline—Pain—Docetaxel—lung cancer	3.16e-05	0.000206	CcSEcCtD
Selegiline—Constipation—Docetaxel—lung cancer	3.16e-05	0.000206	CcSEcCtD
Selegiline—Back pain—Methotrexate—lung cancer	3.15e-05	0.000205	CcSEcCtD
Selegiline—Pruritus—Etoposide—lung cancer	3.14e-05	0.000205	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—lung cancer	3.12e-05	0.000204	CcSEcCtD
Selegiline—Asthenia—Paclitaxel—lung cancer	3.12e-05	0.000204	CcSEcCtD
Selegiline—Nausea—Gemcitabine—lung cancer	3.09e-05	0.000201	CcSEcCtD
Selegiline—Vomiting—Cisplatin—lung cancer	3.08e-05	0.000201	CcSEcCtD
Selegiline—Pruritus—Paclitaxel—lung cancer	3.08e-05	0.000201	CcSEcCtD
Selegiline—Vision blurred—Methotrexate—lung cancer	3.07e-05	0.0002	CcSEcCtD
Selegiline—Rash—Cisplatin—lung cancer	3.06e-05	0.000199	CcSEcCtD
Selegiline—Dermatitis—Cisplatin—lung cancer	3.05e-05	0.000199	CcSEcCtD
Selegiline—Feeling abnormal—Docetaxel—lung cancer	3.04e-05	0.000198	CcSEcCtD
Selegiline—Diarrhoea—Etoposide—lung cancer	3.04e-05	0.000198	CcSEcCtD
Selegiline—Ill-defined disorder—Methotrexate—lung cancer	3.02e-05	0.000197	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—lung cancer	3.02e-05	0.000197	CcSEcCtD
Selegiline—Gastrointestinal pain—Docetaxel—lung cancer	3.02e-05	0.000197	CcSEcCtD
Selegiline—Anaemia—Methotrexate—lung cancer	3.01e-05	0.000196	CcSEcCtD
Selegiline—Flushing—Doxorubicin—lung cancer	3.01e-05	0.000196	CcSEcCtD
Selegiline—Diarrhoea—Paclitaxel—lung cancer	2.98e-05	0.000194	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—lung cancer	2.94e-05	0.000192	CcSEcCtD
Selegiline—Malaise—Methotrexate—lung cancer	2.94e-05	0.000192	CcSEcCtD
Selegiline—Dizziness—Etoposide—lung cancer	2.94e-05	0.000191	CcSEcCtD
Selegiline—Vertigo—Methotrexate—lung cancer	2.93e-05	0.000191	CcSEcCtD
Selegiline—Abdominal pain—Docetaxel—lung cancer	2.92e-05	0.00019	CcSEcCtD
Selegiline—Body temperature increased—Docetaxel—lung cancer	2.92e-05	0.00019	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—lung cancer	2.92e-05	0.00019	CcSEcCtD
Selegiline—Chills—Doxorubicin—lung cancer	2.91e-05	0.00019	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—lung cancer	2.9e-05	0.000189	CcSEcCtD
Selegiline—Dizziness—Paclitaxel—lung cancer	2.88e-05	0.000188	CcSEcCtD
Selegiline—Nausea—Cisplatin—lung cancer	2.88e-05	0.000188	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—lung cancer	2.87e-05	0.000187	CcSEcCtD
Selegiline—Cough—Methotrexate—lung cancer	2.84e-05	0.000185	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—lung cancer	2.84e-05	0.000185	CcSEcCtD
Selegiline—Convulsion—Methotrexate—lung cancer	2.82e-05	0.000184	CcSEcCtD
Selegiline—Vomiting—Etoposide—lung cancer	2.82e-05	0.000184	CcSEcCtD
Selegiline—Erythema—Doxorubicin—lung cancer	2.82e-05	0.000184	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—lung cancer	2.82e-05	0.000184	CcSEcCtD
Selegiline—Rash—Etoposide—lung cancer	2.8e-05	0.000182	CcSEcCtD
Selegiline—Dermatitis—Etoposide—lung cancer	2.8e-05	0.000182	CcSEcCtD
Selegiline—Headache—Etoposide—lung cancer	2.78e-05	0.000181	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—lung cancer	2.78e-05	0.000181	CcSEcCtD
Selegiline—Chest pain—Methotrexate—lung cancer	2.78e-05	0.000181	CcSEcCtD
Selegiline—Myalgia—Methotrexate—lung cancer	2.78e-05	0.000181	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—lung cancer	2.78e-05	0.000181	CcSEcCtD
Selegiline—Tension—Doxorubicin—lung cancer	2.77e-05	0.00018	CcSEcCtD
Selegiline—Vomiting—Paclitaxel—lung cancer	2.77e-05	0.00018	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—lung cancer	2.76e-05	0.00018	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.76e-05	0.00018	CcSEcCtD
Selegiline—Rash—Paclitaxel—lung cancer	2.75e-05	0.000179	CcSEcCtD
Selegiline—Dermatitis—Paclitaxel—lung cancer	2.74e-05	0.000179	CcSEcCtD
Selegiline—Discomfort—Methotrexate—lung cancer	2.74e-05	0.000179	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—lung cancer	2.74e-05	0.000179	CcSEcCtD
Selegiline—Back pain—Doxorubicin—lung cancer	2.73e-05	0.000178	CcSEcCtD
Selegiline—Headache—Paclitaxel—lung cancer	2.73e-05	0.000178	CcSEcCtD
Selegiline—Hypersensitivity—Docetaxel—lung cancer	2.72e-05	0.000177	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—lung cancer	2.71e-05	0.000177	CcSEcCtD
Selegiline—Confusional state—Methotrexate—lung cancer	2.68e-05	0.000175	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—lung cancer	2.66e-05	0.000173	CcSEcCtD
Selegiline—Asthenia—Docetaxel—lung cancer	2.65e-05	0.000173	CcSEcCtD
Selegiline—Infection—Methotrexate—lung cancer	2.64e-05	0.000172	CcSEcCtD
Selegiline—Nausea—Etoposide—lung cancer	2.64e-05	0.000172	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—lung cancer	2.62e-05	0.000171	CcSEcCtD
Selegiline—Pruritus—Docetaxel—lung cancer	2.61e-05	0.00017	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—lung cancer	2.61e-05	0.00017	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—lung cancer	2.61e-05	0.00017	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—lung cancer	2.6e-05	0.00017	CcSEcCtD
Selegiline—Agitation—Doxorubicin—lung cancer	2.59e-05	0.000169	CcSEcCtD
Selegiline—Nausea—Paclitaxel—lung cancer	2.59e-05	0.000169	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—lung cancer	2.58e-05	0.000168	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—lung cancer	2.57e-05	0.000168	CcSEcCtD
Selegiline—Malaise—Doxorubicin—lung cancer	2.55e-05	0.000166	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—lung cancer	2.54e-05	0.000165	CcSEcCtD
Selegiline—Anorexia—Methotrexate—lung cancer	2.54e-05	0.000165	CcSEcCtD
Selegiline—Syncope—Doxorubicin—lung cancer	2.53e-05	0.000165	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—lung cancer	2.53e-05	0.000165	CcSEcCtD
Selegiline—Diarrhoea—Docetaxel—lung cancer	2.53e-05	0.000165	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—lung cancer	2.49e-05	0.000163	CcSEcCtD
Selegiline—Hypotension—Methotrexate—lung cancer	2.49e-05	0.000162	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—lung cancer	2.48e-05	0.000162	CcSEcCtD
Selegiline—Cough—Doxorubicin—lung cancer	2.46e-05	0.00016	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—lung cancer	2.45e-05	0.000159	CcSEcCtD
Selegiline—Dizziness—Docetaxel—lung cancer	2.44e-05	0.000159	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—lung cancer	2.44e-05	0.000159	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—lung cancer	2.42e-05	0.000158	CcSEcCtD
Selegiline—Insomnia—Methotrexate—lung cancer	2.41e-05	0.000157	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—lung cancer	2.4e-05	0.000157	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—lung cancer	2.4e-05	0.000157	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—lung cancer	2.4e-05	0.000157	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—lung cancer	2.39e-05	0.000156	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—lung cancer	2.39e-05	0.000156	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.39e-05	0.000155	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—lung cancer	2.37e-05	0.000155	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—lung cancer	2.37e-05	0.000155	CcSEcCtD
Selegiline—Somnolence—Methotrexate—lung cancer	2.37e-05	0.000154	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—lung cancer	2.35e-05	0.000153	CcSEcCtD
Selegiline—Vomiting—Docetaxel—lung cancer	2.35e-05	0.000153	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—lung cancer	2.34e-05	0.000153	CcSEcCtD
Selegiline—Rash—Docetaxel—lung cancer	2.33e-05	0.000152	CcSEcCtD
Selegiline—Dermatitis—Docetaxel—lung cancer	2.33e-05	0.000151	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—lung cancer	2.32e-05	0.000151	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—lung cancer	2.31e-05	0.000151	CcSEcCtD
Selegiline—Headache—Docetaxel—lung cancer	2.31e-05	0.000151	CcSEcCtD
Selegiline—Oedema—Doxorubicin—lung cancer	2.3e-05	0.00015	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—lung cancer	2.3e-05	0.00015	CcSEcCtD
Selegiline—Fatigue—Methotrexate—lung cancer	2.29e-05	0.000149	CcSEcCtD
Selegiline—Infection—Doxorubicin—lung cancer	2.29e-05	0.000149	CcSEcCtD
Selegiline—Pain—Methotrexate—lung cancer	2.28e-05	0.000148	CcSEcCtD
Selegiline—Shock—Doxorubicin—lung cancer	2.27e-05	0.000148	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—lung cancer	2.26e-05	0.000147	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—lung cancer	2.26e-05	0.000147	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—lung cancer	2.25e-05	0.000146	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—lung cancer	2.24e-05	0.000146	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—lung cancer	2.23e-05	0.000145	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—lung cancer	2.2e-05	0.000143	CcSEcCtD
Selegiline—Nausea—Docetaxel—lung cancer	2.19e-05	0.000143	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—lung cancer	2.19e-05	0.000143	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—lung cancer	2.18e-05	0.000142	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—lung cancer	2.15e-05	0.00014	CcSEcCtD
Selegiline—Urticaria—Methotrexate—lung cancer	2.11e-05	0.000138	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—lung cancer	2.1e-05	0.000137	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—lung cancer	2.1e-05	0.000137	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.1e-05	0.000137	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—lung cancer	2.08e-05	0.000136	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—lung cancer	2.07e-05	0.000135	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—lung cancer	2.05e-05	0.000134	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—lung cancer	2.05e-05	0.000133	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—lung cancer	2.03e-05	0.000132	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—lung cancer	2e-05	0.00013	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—lung cancer	1.99e-05	0.00013	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—lung cancer	1.99e-05	0.000129	CcSEcCtD
Selegiline—Pain—Doxorubicin—lung cancer	1.97e-05	0.000128	CcSEcCtD
Selegiline—Constipation—Doxorubicin—lung cancer	1.97e-05	0.000128	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—lung cancer	1.96e-05	0.000128	CcSEcCtD
Selegiline—Asthenia—Methotrexate—lung cancer	1.91e-05	0.000124	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—lung cancer	1.9e-05	0.000124	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—lung cancer	1.88e-05	0.000123	CcSEcCtD
Selegiline—Pruritus—Methotrexate—lung cancer	1.88e-05	0.000123	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—lung cancer	1.83e-05	0.000119	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—lung cancer	1.82e-05	0.000119	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—lung cancer	1.82e-05	0.000119	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—lung cancer	1.82e-05	0.000119	CcSEcCtD
Selegiline—Dizziness—Methotrexate—lung cancer	1.76e-05	0.000115	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—lung cancer	1.7e-05	0.000111	CcSEcCtD
Selegiline—Vomiting—Methotrexate—lung cancer	1.69e-05	0.00011	CcSEcCtD
Selegiline—Rash—Methotrexate—lung cancer	1.68e-05	0.000109	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—lung cancer	1.68e-05	0.000109	CcSEcCtD
Selegiline—Headache—Methotrexate—lung cancer	1.67e-05	0.000109	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—lung cancer	1.65e-05	0.000108	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—lung cancer	1.63e-05	0.000106	CcSEcCtD
Selegiline—Nausea—Methotrexate—lung cancer	1.58e-05	0.000103	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—lung cancer	1.58e-05	0.000103	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—lung cancer	1.52e-05	9.92e-05	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—lung cancer	1.46e-05	9.54e-05	CcSEcCtD
Selegiline—Rash—Doxorubicin—lung cancer	1.45e-05	9.46e-05	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—lung cancer	1.45e-05	9.45e-05	CcSEcCtD
Selegiline—Headache—Doxorubicin—lung cancer	1.44e-05	9.4e-05	CcSEcCtD
Selegiline—Nausea—Doxorubicin—lung cancer	1.37e-05	8.91e-05	CcSEcCtD
Selegiline—CYP2C8—Metabolism—STK11—lung cancer	4.59e-06	5.55e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—TYMS—lung cancer	4.57e-06	5.52e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA4—lung cancer	4.56e-06	5.51e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NQO1—lung cancer	4.55e-06	5.49e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.53e-06	5.47e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTM1—lung cancer	4.52e-06	5.46e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2E1—lung cancer	4.49e-06	5.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ADCY1—lung cancer	4.48e-06	5.42e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCG2—lung cancer	4.48e-06	5.42e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.45e-06	5.38e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA2—lung cancer	4.45e-06	5.37e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NQO1—lung cancer	4.44e-06	5.36e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.41e-06	5.33e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO2—lung cancer	4.4e-06	5.31e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HPGDS—lung cancer	4.4e-06	5.31e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP1A1—lung cancer	4.37e-06	5.28e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.37e-06	5.28e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ERCC2—lung cancer	4.34e-06	5.24e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.31e-06	5.21e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.31e-06	5.21e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTA1—lung cancer	4.29e-06	5.18e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP1A1—lung cancer	4.28e-06	5.17e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTT1—lung cancer	4.26e-06	5.15e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—lung cancer	4.25e-06	5.13e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ERCC2—lung cancer	4.25e-06	5.13e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—lung cancer	4.24e-06	5.13e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCC3—lung cancer	4.24e-06	5.13e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.23e-06	5.11e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2E1—lung cancer	4.23e-06	5.11e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GCLC—lung cancer	4.21e-06	5.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2A6—lung cancer	4.21e-06	5.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.2e-06	5.07e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP2E1—lung cancer	4.19e-06	5.07e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CB—lung cancer	4.19e-06	5.06e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NQO1—lung cancer	4.18e-06	5.05e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTGS2—lung cancer	4.15e-06	5.02e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NQO1—lung cancer	4.15e-06	5.01e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CAT—lung cancer	4.13e-06	5e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.11e-06	4.97e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKR1C1—lung cancer	4.11e-06	4.97e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—STK11—lung cancer	4.1e-06	4.95e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—lung cancer	4.07e-06	4.92e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.06e-06	4.91e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—POMC—lung cancer	4.04e-06	4.88e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.02e-06	4.86e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ABCB1—lung cancer	4.02e-06	4.86e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—STK11—lung cancer	4e-06	4.83e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO1—lung cancer	3.99e-06	4.83e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—UGT1A1—lung cancer	3.99e-06	4.82e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.98e-06	4.81e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—TYMS—lung cancer	3.95e-06	4.77e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CREBBP—lung cancer	3.93e-06	4.75e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.93e-06	4.75e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTM1—lung cancer	3.9e-06	4.72e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.85e-06	4.65e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GNG11—lung cancer	3.85e-06	4.65e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—lung cancer	3.79e-06	4.58e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—STK11—lung cancer	3.77e-06	4.55e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—APOA1—lung cancer	3.75e-06	4.53e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—STK11—lung cancer	3.74e-06	4.52e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—lung cancer	3.73e-06	4.51e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—lung cancer	3.7e-06	4.47e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP1A1—lung cancer	3.7e-06	4.47e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CAT—lung cancer	3.69e-06	4.46e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ALB—lung cancer	3.68e-06	4.45e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—APOA1—lung cancer	3.67e-06	4.44e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ERCC2—lung cancer	3.67e-06	4.44e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.67e-06	4.43e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALDOA—lung cancer	3.66e-06	4.43e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—lung cancer	3.62e-06	4.37e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CAT—lung cancer	3.6e-06	4.35e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ABCB1—lung cancer	3.59e-06	4.34e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2E1—lung cancer	3.58e-06	4.33e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOA3—lung cancer	3.56e-06	4.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NQO1—lung cancer	3.54e-06	4.28e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—TYMS—lung cancer	3.53e-06	4.26e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.51e-06	4.24e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—lung cancer	3.49e-06	4.21e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTM1—lung cancer	3.48e-06	4.21e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.47e-06	4.19e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCG2—lung cancer	3.46e-06	4.18e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ADCY1—lung cancer	3.46e-06	4.18e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—lung cancer	3.46e-06	4.18e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—EP300—lung cancer	3.45e-06	4.17e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—TYMS—lung cancer	3.44e-06	4.16e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.44e-06	4.15e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—lung cancer	3.42e-06	4.14e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTM1—lung cancer	3.4e-06	4.11e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CAT—lung cancer	3.39e-06	4.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HPGDS—lung cancer	3.39e-06	4.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO2—lung cancer	3.39e-06	4.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.37e-06	4.07e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CAT—lung cancer	3.36e-06	4.07e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—lung cancer	3.35e-06	4.05e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.35e-06	4.04e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—lung cancer	3.32e-06	4.02e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP1A1—lung cancer	3.3e-06	3.99e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ABCB1—lung cancer	3.3e-06	3.99e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTT1—lung cancer	3.29e-06	3.98e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ERCC2—lung cancer	3.28e-06	3.96e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ABCB1—lung cancer	3.27e-06	3.95e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—POMC—lung cancer	3.26e-06	3.94e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2A6—lung cancer	3.25e-06	3.93e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GCLC—lung cancer	3.25e-06	3.93e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—lung cancer	3.25e-06	3.93e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—TYMS—lung cancer	3.24e-06	3.92e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP1A1—lung cancer	3.22e-06	3.9e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTGS2—lung cancer	3.22e-06	3.89e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—TYMS—lung cancer	3.21e-06	3.88e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTM1—lung cancer	3.21e-06	3.87e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ERCC2—lung cancer	3.2e-06	3.86e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—STK11—lung cancer	3.19e-06	3.86e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—POMC—lung cancer	3.19e-06	3.86e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTM1—lung cancer	3.18e-06	3.84e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—APOA1—lung cancer	3.18e-06	3.84e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CREBBP—lung cancer	3.17e-06	3.84e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CREBBP—lung cancer	3.11e-06	3.76e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO1—lung cancer	3.08e-06	3.73e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.04e-06	3.67e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP1A1—lung cancer	3.04e-06	3.67e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ERCC2—lung cancer	3.01e-06	3.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP1A1—lung cancer	3.01e-06	3.64e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—lung cancer	3.01e-06	3.64e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3e-06	3.62e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ERCC2—lung cancer	2.99e-06	3.61e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ALB—lung cancer	2.97e-06	3.59e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—lung cancer	2.95e-06	3.57e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—lung cancer	2.95e-06	3.56e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALB—lung cancer	2.91e-06	3.52e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—lung cancer	2.9e-06	3.5e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CAT—lung cancer	2.88e-06	3.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.86e-06	3.45e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—APOA1—lung cancer	2.83e-06	3.42e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—lung cancer	2.81e-06	3.4e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCB1—lung cancer	2.8e-06	3.38e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—APOA1—lung cancer	2.77e-06	3.34e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2E1—lung cancer	2.77e-06	3.34e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—POMC—lung cancer	2.76e-06	3.33e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—TYMS—lung cancer	2.75e-06	3.32e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NQO1—lung cancer	2.73e-06	3.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTM1—lung cancer	2.72e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.71e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CREBBP—lung cancer	2.69e-06	3.25e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—EP300—lung cancer	2.68e-06	3.24e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—lung cancer	2.62e-06	3.17e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—APOA1—lung cancer	2.61e-06	3.15e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTGS2—lung cancer	2.6e-06	3.14e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—lung cancer	2.59e-06	3.13e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—APOA1—lung cancer	2.58e-06	3.12e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP1A1—lung cancer	2.57e-06	3.11e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—lung cancer	2.57e-06	3.11e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—lung cancer	2.55e-06	3.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ERCC2—lung cancer	2.55e-06	3.08e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—lung cancer	2.55e-06	3.08e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTGS2—lung cancer	2.55e-06	3.08e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—lung cancer	2.53e-06	3.05e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALB—lung cancer	2.52e-06	3.04e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.47e-06	2.99e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—STK11—lung cancer	2.46e-06	2.98e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—POMC—lung cancer	2.46e-06	2.98e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—POMC—lung cancer	2.4e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CREBBP—lung cancer	2.4e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—lung cancer	2.38e-06	2.88e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—lung cancer	2.36e-06	2.85e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CREBBP—lung cancer	2.34e-06	2.83e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—lung cancer	2.28e-06	2.76e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—lung cancer	2.27e-06	2.75e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—lung cancer	2.27e-06	2.74e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—POMC—lung cancer	2.27e-06	2.74e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—POMC—lung cancer	2.25e-06	2.71e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALB—lung cancer	2.25e-06	2.71e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—lung cancer	2.22e-06	2.68e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—lung cancer	2.22e-06	2.68e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—lung cancer	2.22e-06	2.68e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CAT—lung cancer	2.22e-06	2.68e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—APOA1—lung cancer	2.21e-06	2.67e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CREBBP—lung cancer	2.21e-06	2.67e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTGS2—lung cancer	2.2e-06	2.66e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALB—lung cancer	2.19e-06	2.65e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CREBBP—lung cancer	2.19e-06	2.64e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—EP300—lung cancer	2.16e-06	2.61e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCB1—lung cancer	2.16e-06	2.61e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TYMS—lung cancer	2.12e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—EP300—lung cancer	2.12e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.11e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTM1—lung cancer	2.1e-06	2.53e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—lung cancer	2.09e-06	2.53e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—lung cancer	2.09e-06	2.52e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—lung cancer	2.07e-06	2.51e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALB—lung cancer	2.07e-06	2.5e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALB—lung cancer	2.05e-06	2.47e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—lung cancer	2.02e-06	2.44e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP1A1—lung cancer	1.99e-06	2.4e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—lung cancer	1.98e-06	2.4e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—lung cancer	1.98e-06	2.4e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ERCC2—lung cancer	1.97e-06	2.38e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTGS2—lung cancer	1.96e-06	2.37e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—lung cancer	1.94e-06	2.34e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—lung cancer	1.92e-06	2.32e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—POMC—lung cancer	1.92e-06	2.32e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTGS2—lung cancer	1.92e-06	2.32e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CREBBP—lung cancer	1.87e-06	2.26e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—EP300—lung cancer	1.83e-06	2.21e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—lung cancer	1.82e-06	2.2e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—lung cancer	1.81e-06	2.18e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTGS2—lung cancer	1.81e-06	2.18e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTGS2—lung cancer	1.79e-06	2.16e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—lung cancer	1.77e-06	2.14e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALB—lung cancer	1.75e-06	2.11e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—lung cancer	1.71e-06	2.07e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—APOA1—lung cancer	1.7e-06	2.06e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—lung cancer	1.67e-06	2.02e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—EP300—lung cancer	1.63e-06	1.97e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—lung cancer	1.62e-06	1.96e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—lung cancer	1.6e-06	1.93e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—EP300—lung cancer	1.59e-06	1.93e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—lung cancer	1.58e-06	1.9e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—lung cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—lung cancer	1.56e-06	1.89e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—lung cancer	1.56e-06	1.88e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—lung cancer	1.54e-06	1.87e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTGS2—lung cancer	1.53e-06	1.85e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—EP300—lung cancer	1.5e-06	1.82e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—EP300—lung cancer	1.49e-06	1.8e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—POMC—lung cancer	1.48e-06	1.79e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CREBBP—lung cancer	1.44e-06	1.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—lung cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—lung cancer	1.35e-06	1.64e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALB—lung cancer	1.35e-06	1.63e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—lung cancer	1.34e-06	1.61e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—lung cancer	1.31e-06	1.58e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—lung cancer	1.28e-06	1.55e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—EP300—lung cancer	1.27e-06	1.54e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—lung cancer	1.21e-06	1.46e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—lung cancer	1.19e-06	1.44e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTGS2—lung cancer	1.18e-06	1.43e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—lung cancer	1.18e-06	1.43e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—lung cancer	1.11e-06	1.34e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—lung cancer	1.11e-06	1.34e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—lung cancer	1.1e-06	1.33e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—lung cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—lung cancer	9.87e-07	1.19e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—EP300—lung cancer	9.83e-07	1.19e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—lung cancer	9.64e-07	1.16e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—lung cancer	9.42e-07	1.14e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—lung cancer	9.08e-07	1.1e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—lung cancer	9e-07	1.09e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—lung cancer	7.69e-07	9.3e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—lung cancer	7.27e-07	8.78e-06	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—lung cancer	5.94e-07	7.17e-06	CbGpPWpGaD
